AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metfo SR 500 Tablet

Prescription Icon
Prescription Required

Marketer

Aishwarya Healthcare

Salt Composition

Metformin (500mg)

Overview Metfo SR 500 Tablet

Glucovance XR 500mg tablets are prescribed for managing type 2 diabetes. This medication regulates blood glucose, mitigating the risk of diabetes-related complications. It's also indicated for treating Polycystic Ovary Syndrome (PCOS) in women. For optimal absorption and to minimize gastrointestinal upset, Glucovance XR 500mg should be ingested with meals, consistently at the same time daily. Discontinuation should only occur under physician guidance. Maintaining a healthy lifestyle is crucial for diabetes control; adherence to the prescribed diet and exercise plan is essential. Commonly reported side effects include nausea, diarrhea, vomiting, gas, weakness, indigestion, abdominal pain, headache, and appetite loss. Hypoglycemia (low blood sugar) may occur, particularly when combined with other diabetes medications, alcohol, or missed meals. Regular blood glucose monitoring is recommended. Prior to commencing treatment, inform your doctor of any existing kidney, liver, or heart conditions. Pregnant or lactating individuals should seek medical counsel before use. Kidney function will be assessed before treatment begins. Limit alcohol consumption to reduce the potential for adverse reactions.

Uses of Metfo SR 500 Tablet

Management of type 2 diabetes and polycystic ovary syndrome

Major Benefits of Metfo SR 500 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or fracture it. Consume Metfo SR 500 Tablet with a meal.

Common Side effects of Metfo SR 500 Tablet:

  • Diarrhea
  • Headache
  • Vomiting
  • Nausea
  • Flatulence
  • Abdominal discomfort
  • Weakness

How to use Metfo SR 500 Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Metfo SR 500 Tablet with a meal.

How Metfo SR 500 Tablet works:

Extended-release metformin 500mg tablets are a biguanide class antidiabetic drug. Their mechanism involves reducing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol and Metfo SR 500 Tablets should not be taken together.

PregnancyPregnancySAFE IF PRESCRIBED

Extended-release metformin 500 mg tablets are typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human studies are scarce.

Breast feedingBreast feedingCAUTION

Extended-release metformin 500mg tablets require careful consideration during lactation. Breastfeeding is advised against until maternal treatment concludes and the medication is fully cleared from the mother's system.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Metfo SR 500mg tablets cautiously, potentially requiring dosage modification under medical supervision. However, Metfo SR 500mg tablets are contraindicated in individuals with severe kidney disease.

LiverLiverUNSAFE

Patients with liver disease should likely avoid Metfo SR 500 Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Metfo SR 500 Tablet :

Should you forget a Metfo SR 500 Tablet dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metfo SR 500 Tablet

LabelValue
Type of Compound Guanidine-based compound
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Metfo SR 500 Tablet

Individuals with type 2 diabetes exhibit impaired responsiveness to their body's own insulin. This results in elevated blood glucose. Metfo SR 500 Tablet employs a multifaceted approach to lower these increased blood sugar levels. The tablet reduces hepatic glucose production, diminishes intestinal glucose absorption following meals, and enhances insulin sensitivity in bodily tissues. This facilitates improved glucose uptake from the bloodstream. Consequently, it promotes more effective utilization of naturally produced insulin.
Metformin extended-release 500mg tablets have demonstrated weight reduction benefits in overweight and obese individuals. This weight loss effect may also be observed in overweight, obese individuals pre-diabetic. Furthermore, insulin-resistant or insulin-sensitive patients may experience weight loss. However, self-medicating with this drug for weight management is inadvisable; physician consultation is necessary.
Metformin extended-release 500mg tablets are a primary treatment for elevated blood glucose. This medication regulates blood sugar by enhancing the body's insulin sensitivity, reducing hepatic glucose production, and limiting intestinal glucose absorption. In contrast to other oral hypoglycemics, monotherapy with Metformin extended-release 500mg tablets infrequently leads to hypoglycemia due to its mechanism of action, which doesn't stimulate excessive insulin release. Beyond glycemic control, it also aids in weight management.
Metformin 500mg extended-release tablets typically do not induce drowsiness and are generally well-received. Infrequently, though, they may lead to sleep disturbances or insomnia. Somnolence can be a symptom of lactic acidosis, a serious adverse reaction more likely in individuals with impaired kidney function. Consult your physician if fatigue or sleepiness develops during treatment with Metformin 500mg extended-release tablets.
Administer Metfo SR 500 tablets during or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily prescriptions, consume with breakfast. Twice-daily regimens should involve one tablet with breakfast and one with dinner. For thrice-daily use, distribute doses among breakfast, lunch, and dinner. Consuming Metfo SR 500 with food mitigates gastrointestinal distress, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to endogenous insulin. This leads to elevated blood glucose levels. Metfo SR 500 Tablet employs multiple mechanisms to lower these elevated blood sugar levels. It reduces hepatic glucose production, diminishes intestinal glucose absorption postprandially, and enhances insulin sensitivity in tissues. This combined action facilitates improved glucose uptake from the bloodstream. The tablet also promotes a more effective response to naturally produced insulin.
Metformin extended-release 500mg tablets have demonstrated weight reduction in overweight or obese patients. This weight loss effect may also be observed, albeit modestly, in overweight or obese individuals predisposed to diabetes. Furthermore, individuals with insulin resistance or sensitivity may experience weight loss. However, self-initiating this medication for weight management is inadvisable; physician consultation is essential.
Metformin SR 500mg tablets are frequently a first-line treatment for hyperglycemia. This medication manages blood glucose by enhancing insulin sensitivity, reducing hepatic glucose production, and limiting intestinal glucose absorption. Differing from other oral hypoglycemics, Metformin SR 500mg, when used monotherapy, infrequently induces hypoglycemia due to its mechanism that doesn't stimulate excessive insulin release. Beyond glycemic control, it also aids in weight management.
Metformin 500 mg extended-release tablets generally don't induce drowsiness and are typically well-tolerated. Infrequently, however, they may lead to sleep disturbances or insomnia. Excessive sleepiness can be a symptom of lactic acidosis, a serious adverse reaction more likely in individuals with impaired kidney function. Consult your physician if fatigue or somnolence develops during treatment with Metformin 500 mg extended-release tablets.
Administer Metfo SR 500 Tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily prescriptions, morning administration with breakfast is recommended. Twice-daily regimens should involve one tablet with breakfast and one with dinner. For thrice-daily doses, distribute the tablets among breakfast, lunch, and dinner. Consuming Metfo SR 500 Tablets with food mitigates potential gastrointestinal issues such as indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their body's naturally produced insulin. This results in elevated blood glucose levels. Metfo SR 500 Tablet works through multiple mechanisms to lower these elevated blood sugar levels. It reduces hepatic glucose production, diminishes intestinal glucose absorption post-prandially, and enhances insulin sensitivity in tissues and organs. This improved sensitivity facilitates increased glucose uptake from the bloodstream. Consequently, the body's response to its endogenous insulin production is also improved.
Metformin extended-release 500mg tablets have demonstrated weight reduction benefits in overweight or obese patients. This weight loss effect may also be observed, albeit modestly, in overweight and obese individuals predisposed to diabetes. Furthermore, individuals with insulin resistance or sensitivity may experience similar results. However, self-initiating this medication for weight management is strongly discouraged; physician consultation is mandatory.
Extended-release metformin 500 mg tablets are frequently the initial treatment for elevated blood glucose. This medication manages blood sugar by enhancing insulin sensitivity, reducing hepatic glucose production, and diminishing intestinal glucose absorption. In contrast to other oral hypoglycemics, metformin monotherapy infrequently leads to hypoglycemia because it doesn't stimulate excessive insulin release. Beyond its glycemic control benefits, it also aids in weight management.
Metformin 500mg extended-release tablets generally don't induce drowsiness and are typically well-received. Infrequently, however, they might lead to sleep disturbances or insomnia. Drowsiness can signal a severe adverse reaction known as lactic acidosis, especially prevalent in individuals with impaired kidney function. Consult your physician if fatigue or sleepiness develops during treatment with Metformin 500mg extended-release tablets.
Administer Metfo SR 500 tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily prescriptions, consume with breakfast. Twice-daily regimens should involve one tablet in the morning and one in the evening, with meals. Three times daily, distribute doses with breakfast, lunch, and dinner. Ingesting Metfo SR 500 with food mitigates potential gastrointestinal distress, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Metfo SR 500 Tablet
21
MRP 24
11% off